Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/15/2012WO2012031518A1 Localized pegylated modifications of exendin-4 analogs and use thereof
03/15/2012WO2012031327A1 Modified relaxin polypeptides
03/15/2012WO2012031326A1 Single chain relaxin polypeptides
03/15/2012WO2011119716A3 Flavivirus host range mutations and uses thereof
03/15/2012WO2011118954A3 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells
03/15/2012WO2011020319A8 Fusion protein regulating plasma glucose and lipid, its preparation method and use
03/15/2012WO2006024954A9 Domains and epitopes of meningococcal protein nmb1870
03/15/2012WO2003041560A3 Compounds and methods for treatment and diagnosis of chlamydial infection
03/15/2012US20120066793 Methods and compositions for controlling plant pests
03/15/2012US20120066792 Novel Genes Involved In Biosynthesis
03/15/2012US20120066779 Hepatitis c receptor protein cd81
03/15/2012US20120066775 Stresscopins and their Uses
03/15/2012US20120065574 Isoform nell-1 peptide
03/15/2012US20120065429 Water-soluble polymer alkanals
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065378 Selective extraction of prolamin proteins from freshwater or saltwater algae
03/15/2012US20120065376 Methods of processing recombinant procollagen
03/15/2012US20120065375 Recombinant organism and protein produced by the recombinant organism
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065373 Dengue vaccine, pharmaceutical composition comprising the same, and nucleotide sequence
03/15/2012US20120065372 Dragline protein
03/15/2012US20120065371 Recombinant proteins from filoviruses and their use
03/15/2012US20120065369 Long lasting fusion peptide inhibitors for hiv infection
03/15/2012US20120065368 Cyclodextrin-based polymers for therapeutics delivery
03/15/2012US20120065365 Stable Radiopharmaceutical Compositions and Methods for Their Preparation
03/15/2012US20120065344 Compound modified by a phosphoramidate and/or phosphonamide group and use thereof
03/15/2012US20120065330 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
03/15/2012US20120065254 C5A binding nucleic acids and the use thereof
03/15/2012US20120065139 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
03/15/2012US20120065136 Recombinant factor viii having enhanced stability following mutation at the a1-c2 domain interface
03/15/2012US20120065135 Genetically Modified TFPI And Method Of Making The Same
03/15/2012US20120065133 Artificial Oxygen Transport Protein
03/15/2012US20120065127 Novel Bacillus thuringiensis Gene with Lepidopteran Activity
03/15/2012US20120065106 Methods and Compositions for Enhanced Protein Expression and Purification
03/15/2012US20120065104 Compositions and methods for a membrane protein crystallization screening kit
03/15/2012US20120065083 Method and apparatus for predicting susceptibility to a developmental disorder
03/15/2012US20120064626 B7-h7 antibodies and method of use
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064621 Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide
03/15/2012US20120064599 Hybridization linkers
03/15/2012US20120064598 Mutation of the parkin gene, compositions, methods and uses
03/15/2012US20120064578 Chromosome-based platforms
03/15/2012US20120064572 Bacterial Virulence Factors And Uses Thereof
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064548 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064541 N-glycan core beta-galactosyltransferase and uses thereof
03/15/2012US20120064524 Tumor suppressor gene, p47ing3
03/15/2012US20120064169 Multiple antigen delivery system using hepatitis e virus-like particle
03/15/2012US20120064120 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064119 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064110 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
03/15/2012US20120064101 Compounds and Methods Useful for Detection and Treatment of Cancer
03/15/2012US20120064090 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
03/15/2012US20120064087 Methods to diagnose a required regulation of trophoblast invasion
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064083 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064080 Human LY6-Big Molecules and Methods of Use
03/15/2012US20120064078 Novel Tumor Biomarket
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof
03/15/2012US20120064069 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064068 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064067 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120064029 Compositions for treating nervous system conditions
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012DE102010037469A1 Verfahren zur Reduzierung des Endotoxingehalts in einem kollagenhaltigen Material Process for reducing the endotoxin content in a collagen containing material
03/15/2012CA2814012A1 Modified relaxin polypeptides
03/15/2012CA2813802A1 Single chain relaxin polypeptides
03/15/2012CA2810757A1 Mutant channelrhodopsin 2
03/15/2012CA2809758A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens
03/15/2012CA2808536A1 A thaumatin-based improved sweetening composition and edible products made therewith
03/15/2012CA2714880A1 A novel tumor biomarker
03/14/2012EP2428522A1 Antibodies that bind to PSCA proteins for diagnosis of cancer
03/14/2012EP2428225A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428224A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428223A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428221A1 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition
03/14/2012EP2428220A1 Dengue vaccine, pharmaceutical composition comprising the same, and nucleotide molecule
03/14/2012EP2428122A1 A thaumatin-based improved sweetening composition and edible products made therewith
03/14/2012EP2428116A1 Dragline Protein
03/14/2012EP2428115A1 Genetically modified silkworm for producing recombinant spider dragline protein
03/14/2012EP2427775A1 Peptide ligands of somatostatin receptors
03/14/2012EP2427767A2 Means and methods for recognizing the development of cardiovascular disease in an individual
03/14/2012EP2427766A1 Human fg01 gene and its applications
03/14/2012EP2427577A2 Cocal vesiculovirus envelope pseudotyped retroviral vectors
03/14/2012EP2427557A1 Cho / cert cell lines
03/14/2012EP2427487A2 Method of modifying serine protease inhibitors
03/14/2012EP2427486A1 Method for purifying albumin
03/14/2012EP2427485A2 Cd133 epitopes
03/14/2012EP2427484A1 Method and composition for measuring the amount of vitamin d derivatives
03/14/2012EP2427483A1 Novel heamoglobin and uses thereof
03/14/2012EP2427482A2 Method for purification of target polypeptides
03/14/2012EP2427481A1 Yield enhancement in plants by modulation of ap2 transcription factor
03/14/2012EP2427480A1 Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same
03/14/2012EP2427478A1 Influenza a and b virus replication-inhibiting peptides
03/14/2012EP2427475A1 High penetration prodrug compositions of peptides and peptide-related compounds
03/14/2012EP2427471A2 Novel sugar transporters
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 2916